Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.

le Adélaide, J., Monges, G., Dérdérian, C., Seitz, J. F., Birnbaum, D.
Foilsithe 1995

Carcinoma of the oesophagus

le Seitz, J F, Sarradet, A, François, E, Jacob, J H, Ollivier, J M, Rougier, P, Roussel, A
Foilsithe 2001

Purification and characterization of macrophage migration inhibitory factor as a secretory protein from rat epididymis: evidences for alternative release and transfer to spermatozo...

le Eickhoff, R., Wilhelm, B., Renneberg, H., Wennemuth, G., Bacher, M., Linder, D., Bucala, R., Seitz, J., Meinhardt, A.
Foilsithe 2001

Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a fea...

le Schreyer, A G, Rath, H C, Kikinis, R, Völk, M, Schölmerich, J, Feuerbach, S, Rogler, G, Seitz, J, Herfarth, H
Foilsithe 2005

Gastrointestinal hormone mRNA expression in human colonic adenocarcinomas, hepatic metastases and cell lines

le Monges, G, Biagini, P, Cantaloube, J F, De Micco, P, Parriaux, D, Seitz, J F, Delpero, J R, Hassoun, J
Foilsithe 1996

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

le Conroy, T, Viret, F, François, E, Seitz, J F, Boige, V, Ducreux, M, Ychou, M, Metges, J P, Giovannini, M, Yataghene, Y, Peiffert, D
Foilsithe 2008

Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia Nervosa

le Walton, E., Hibar, D., Yilmaz, Z., Jahanshad, N., Cheung, J., Batury, V.-L., Seitz, J., Bulik, C. M., Thompson, P. M., Ehrlich, Stefan
Foilsithe in Mol Neurobiol (2018)

‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

le Bennouna, J, Perrier, H, Paillot, B, Priou, F, Jacob, J H, Hebbar, M, Bordenave, S, Seitz, J F, Cvitkovic, F, Dorval, E, Malek, K, Tonelli, D, Douillard, J Y
Foilsithe 2006

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

le Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.
Foilsithe in Ann Oncol (2016)

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

le Samalin, E, Bouché, O, Thézenas, S, Francois, E, Adenis, A, Bennouna, J, Taieb, J, Desseigne, F, Seitz, J F, Conroy, T, Galais, M P, Assenat, E, Crapez, E, Poujol, S, Bibeau, F, Boissière, F, Laurent-Puig, P, Ychou, M, Mazard, T
Foilsithe 2014

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population(†)

le Renfro, L. A., Grothey, A., Kerr, D., Haller, D. G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C. L., Alberts, S. R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D. J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Foilsithe in Ann Oncol (2015)